Latest DEF 14A proxy statements

ProCap Financial, Inc. has filed a definitive additional materials proxy statement regarding a proposed transaction involving CFO Silvia and Silvia Merger Sub, Inc., seeking shareholder approval.

Community West Bancshares and United Security Bancshares announce a definitive merger agreement, with USB merging into CWB in an all-stock transaction valued at approximately $193.3 million.

Universal Safety Products, Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on March 27, 2026, to address director elections, auditor ratification, and executive compensation votes.

Warner Bros. Discovery confirms receipt of a revised acquisition proposal from Paramount Skydance, while the Netflix merger agreement remains in effect.

Central Securities Corporation announces its 2026 Annual Meeting of Stockholders to elect seven directors and ratify KPMG LLP as its independent registered public accounting firm.

CooperCompanies delivered double-digit full-year earnings growth and exceeded free cash flow expectations in fiscal 2025, strengthening its foundation for sustainable growth and expanding its share repurchase program.

PAVmed Inc. calls a special meeting to approve significant equity issuances, a corporate governance amendment, and an increase in its equity incentive plan, following a $30 million private placement and debt refinancing.

Aspire Biopharma Holdings, Inc. calls a special meeting to approve a reverse stock split, significant share issuances for capital, and an increase in authorized common stock.

Mission Produce, Inc. reports record 2025 revenues and adjusted net income, alongside significant leadership transitions and robust corporate governance updates ahead of its 2026 Annual Meeting.

Silver Bull Resources, Inc. announced its 2026 Annual Meeting of Shareholders to elect directors and ratify auditors, while continuing to pursue a $374.9 million arbitration claim against Mexico.

EQV Ventures and Presidio secure $25M preferred investment and non-redemption agreement, while Presidio announces a potential $80 million acquisition of producing assets, aiming to increase dividends post-merger.

Citius Pharmaceuticals, Inc. announces its 2026 Annual Meeting of Stockholders to elect directors and ratify its independent auditor.

Citius Pharmaceuticals, Inc. announces its 2026 Annual Meeting of Stockholders to elect directors and ratify its independent auditor, alongside detailed corporate governance and executive compensation disclosures.

Aptose Biosciences Inc. shareholders will vote on a C$2.41 per share cash acquisition by HS North America Ltd., a subsidiary of Hanmi Pharmaceutical Co. Ltd., following a board recommendation.

Cayson Acquisition Corp. files proxy to extend its business combination deadline by up to 12 months, requiring insider contributions and amending redemption rules.

HUMBL, Inc. announces its official name change to TAP Real Estate Technologies, Inc., signaling a strategic pivot towards tokenized real estate assets.

Fortune Brands Innovations, Inc. confirmed receipt of shareholder nominations and is engaging constructively with investor Ed Garden ahead of its 2026 Annual Meeting.

Blue Star Foods Corp. announced an increase in its authorized common stock from 500 million to 5 billion shares to provide greater financial and strategic flexibility.

Veris Residential, Inc. has filed preliminary communications regarding a proposed merger with AC Residential Acquisition LP and its subsidiaries, dated February 23, 2026.

Veris Residential, Inc. announced a definitive merger agreement to be acquired by an investor group led by real estate private equity firm Affinius Capital, with closing expected in Q2 2026.

Exodus Movement, Inc. stockholders approved the 2026 Equity Incentive Plan to attract and retain talent through stock-based compensation.

Veris Residential, Inc. announced its agreement to be sold to a group of investors, with RHO Residential expected to manage the portfolio post-acquisition.

Presidio Investment Holdings, an oil and gas company focused on optimizing existing wells rather than drilling new ones, is going public via a business combination with EQV Ventures Acquisition Corp., offering a 13% annual dividend.

Photronics, Inc. announces its 2026 Annual Meeting of Shareholders to be held virtually on April 8, 2026, to vote on director elections, auditor ratification, and executive compensation.

Ventyx Biosciences filed supplemental disclosures regarding its proposed $14.00 per share cash merger with Eli Lilly, including financial analysis updates, partnership projections, and details on shareholder lawsuits.

MarineMax, Inc. filed a supplement to its definitive proxy statement, disclosing 22,027,414 shares outstanding as of February 13, 2026, for its upcoming annual meeting.

Silexion Therapeutics Corp. calls an extraordinary general meeting to approve a significant increase in authorized share capital and an expanded equity incentive plan to maintain Nasdaq listing and fund operations.

Amicus Therapeutics filed additional proxy materials to supplement its definitive proxy statement for the BioMarin merger, addressing multiple stockholder lawsuits and updating financial projections.

Jack in the Box announced its 2026 Annual Meeting will proceed as scheduled after a court denied an activist investor's attempt to block it.

Aberdeen Investments outlines a new closed-end fund concept, MFS Multi-Market Income Trust, targeting an 11% managed distribution rate through a diversified fixed income strategy.